IL-31 Expression by Inflammatory Cells is Preferentially Elevated in Atopic Dermatitis
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Interleukin-31 (IL-31) is a recently discovered cytokine expressed in many human tissues, and predominantly by activated CD4(+) T cells. IL-31 signals through a heterodimeric receptor consisting of IL-31 receptor alpha (IL-31RA) and oncostatin M receptor beta (OSMR). Earlier studies have shown involvement of IL-31 and its receptor components IL-31RA and OSMR in atopic dermatitis, pruritus and Th2-weighted inflammation at the mRNA level. The aim of this study was to investigate IL-31 protein expression in skin of such conditions. Immunohistochemical staining for IL-31, IL-31RA and OSMR was performed in formalin-fixed paraffin-embedded biopsy specimens. IL-31 expression was increased in the inflammatory infiltrates from skin biopsies taken from subjects with atopic dermatitis, compared with controls (p ≤ 0.05). IL-31, IL-31RA and OSMR protein immunoreactivity was not increased in biopsies from subjects with other Th2-weighted and pruritic skin diseases. Our results confirm, at the protein level, the relationship between IL-31 expression and atopic dermatitis. Our results do not support a general relationship between expression of IL-31/IL-31R and pruritic or Th2-mediated diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148 · cited 1×
“Secondary staining was performed using the alkaline phosphatase anti-alkaline phosphatase method (31).”
MethodInterleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
Dillon, S. R., Sprecher, C., Hammond, A., Bilsborough, J., Rosenfeld-Franklin, M., Presnell, S. R., Haugen, H. S., Maurer, M., Harder, B., Johnston, J., et al. (2004) · Nature Immunology · doi:10.1038/ni1084 · Cited by 1,015
Self-citationIL-31: A new link between T cells and pruritus in atopic skin inflammation
Sonkoly, E., Muller, A., Lauerma, A. I., Pivarcsi, A., Soto, H., Kemeny, L., Alenius, H., Dieu-Nosjean, M.-C., Meller, S., Rieker, J., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.10.033 · Cited by 1,005 · cited 7×
“This supports earlier findings based on mRNA expression and supports a postulated role of IL-31 in AD (3, 13, 16).”
BackgroundResultInfluentialSensory Neuron-Specific GPCR Mrgprs Are Itch Receptors Mediating Chloroquine-Induced Pruritus
Liu, Q., Tang, Z., Surdenikova, L., Kim, S., Patel, K. N., Kim, A., Ru, F., Guan, Y., Weng, H.-J., Geng, Y., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.034 · Cited by 813 · cited 1×
“Pruritus-modulators such as nerve growth factor and semaphorin, receptors such as n opiate or Mrgpr receptors and pathways vary among pruritic diseases and are targets of current investigations (10,32,33).”
BackgroundThe prevalence and clinical characteristics of pruritus among patients with extensive psoriasis
Yosipovitch, G., Goon, A., Wee, J., Chan, Y. H., & Goh, C. L. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03829.x · Cited by 446 · cited 1×
“Itch is commonly reported in psoriasis, while the association of itch with a particular clinical presentation of psoriasis is less well defined (19-21).”
BackgroundNeis, M. M., Peters, B., Dreuw, A., Wenzel, J., Bieber, T., Mauch, C., Krieg, T., Stanzel, S., Heinrich, P. C., Merk, H. F., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.07.015 · Cited by 378 · cited 4×
“IL-31 mRNA expression was not inereased in psoriasis (16), but was upregulated in inflammatory bowel disease mueosa (8).”
BackgroundResultInfluentialBilsborough, J., Leung, D. Y. M., Maurer, M., Howell, M., Boguniewcz, M., Yao, L., Storey, H., LeCiel, C., Harder, B., & Gross, J. A. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.10.046 · Cited by 370 · cited 7×
“This emphasizes a constitutive expression of the receptor components in keratinocytes, as has been shown in earlier investigations (1, 13).”
BackgroundResultInfluentialSelf-citationCorrelation of IL-31 serum levels with severity of atopic dermatitis
Raap, U., Wichmann, K., Bruder, M., Ständer, S., Wedi, B., Kapp, A., & Werfel, T. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.05.047 · Cited by 299 · cited 2×
“In humans, IL-31 serum levels are higher in AD eompared with non-atopie healthy eontrols, and eorrelate with disease aetivity (14).”
BackgroundLew, W., Bowcock, A. M., & Krueger, J. G. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.006 · Cited by 284
Neurophysiological, Neuroimmunological, and Neuroendocrine Basis of Pruritus
Steinhoff, M., Bienenstock, J., Schmelz, M., Maurer, M., Wei, E., & Bíró, T. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700231 · Cited by 265 · cited 2×
“Pruritus-modulators such as nerve growth factor and semaphorin, receptors such as n opiate or Mrgpr receptors and pathways vary among pruritic diseases and are targets of current investigations (10,32,33).”
BackgroundThe histamine H4 receptor is functionally expressed on TH2 cells
Gutzmer, R., Mommert, S., Gschwandtner, M., Zwingmann, K., Stark, H., & Werfel, T. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.12.1110 · Cited by 218 · cited 4×
“It has been shown that staphylococcal enterotoxin B (SEB) upregulates IL-31 in peripheral blood mononuclear cells (3).”
BackgroundInfluentialSignaling by IL-31 and functional consequences
Cornelissen, C., Lüscher-Firzlaff, J., Baron, J. M., & Lüscher, B. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.07.006 · Cited by 207
Prevalence of symptoms experienced by patients with different clinical types of psoriasis
Sampogna, F., Gisondi, P., Melchi, C. F., Amerio, P., Girolomoni, G., Abeni, D., & The Idi Multipurpose Psoriasis Research on Vital Experiences (Improve) Investigators (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06093.x · Cited by 202
Grimstad, Ø., Sawanobori, Y., Vestergaard, C., Bilsborough, J., Olsen, U. B., Grønhøj‐Larsen, C., & Matsushima, K. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00766.x · Cited by 200 · cited 2×
“Investigations in mice, using an anti-IL-31-antibody, showed an initial reduction of scratching behavior waning over time (12).”
BackgroundSelf-citationInvolvement of IL‐31 on scratching behavior in NC/Nga mice with atopic‐like dermatitis
Takaoka, A., Arai, I., Sugimoto, M., Honma, Y., Futaki, N., Nakamura, A., & Nakaike, S. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00405.x · Cited by 152
Immunopathogenesis and therapy of cutaneous T cell lymphoma
Kim, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524826 · Cited by 147
Lee, M. R. F., & Shumack, S. P. (2005) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2005.00187.x · Cited by 131
Itching in patients suffering from psoriasis.
Szepietowski, J. C., Reich, A., & Wiśnicka, B. (2002) · PubMed · Cited by 128
Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis
Takaoka, A., Arai, I., Sugimoto, M., Yamaguchi, A., Tanaka, M., & Nakaike, S. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.040 · Cited by 120 · cited 1×
“In an AD-like murine model (NC/Nga miee), high IL-31 mRNA expression is assoeiated with seratehing behavior (11), while an anti-IL-31 antibody reduees seratehing behavior (12).”
BackgroundChattopadhyay, S., Tracy, E., Liang, P., Robledo, O., Rose-John, S., & Baumann, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609655200 · Cited by 108 · cited 1×
“Through the reeeptor eomplex, IL-31 induees the aetivation of various signaling moleeules, ineluding Jak-, STAT and PI-3 kinase signaling pathways (1,5,6).”
BackgroundPrurigo nodularis Consists of Two Distinct Forms: Early-Onset Atopic and Late-Onset Non-Atopic
Tanaka, M., Aiba, S., Matsumura, N., et al. (2009) · Dermatology · doi:10.1159/000246715 · Cited by 99 · cited 1×
“Prurigo nodularis can be associated with atopy (23) and can be initiated by the scratching in AD (prurigo-type atopic dermatitis).”
BackgroundDiveu, C., Lagrue-Lak-Hal, A.-H., Froger, J., Ravon, E., Grimaud, L., Barbier, F., Hermann, J., Gascan, H., & Chevalier, S. (2004) · PubMed · Cited by 91
Characterization of the Signaling Capacities of the Novel gp130-like Cytokine Receptor
Dreuw, A., Radtke, S., Pflanz, S., Lippok, B. E., Heinrich, P. C., & Hermanns, H. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401122200 · Cited by 90
Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders
Ishii, T., Wang, J., Zhang, W., Mascarenhas, J., Hoffman, R., Dai, Y., Wisch, N., & Xu, M. (2009) · Blood · doi:10.1182/blood-2008-09-179416 · Cited by 84 · cited 2×
“IL31 has been suggested to be a key player in the development of pruritus (1,2, 13).”
BackgroundA common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema
Schulz, F., Marenholz, I., Fölster‐Holst, R., Chen, C. I.-U., Sternjak, A., Baumgrass, R., Esparza-Gordillo, J., Grüber, C., Nickel, R., Schreiber, S., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.07.065 · Cited by 83 · cited 1×
“An IL-31 gene haplotype may be linked to genetie suseeptibility to non-atopie eezema in humans (15).”
BackgroundNakamura, M., Jo, J., Tabata, Y., & Ishikawa, O. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.061249 · Cited by 79 · cited 1×
“Data on the Th 1 - or Th2-weighted inflammation in alopecia areata vary (24-28).”
BackgroundAtopic dermatitis: Therapeutic concepts evolving from new pathophysiologic insights
Jung, T., & Stingl, G. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.09.042 · Cited by 75 · cited 2×
“Acute AD shows an increased number of Th2 cytokines compared with uninvolved or normal skin, while in a later and more chronic stage of AD, Thl-weighted inflammation dominates (17).”
BackgroundHeise, R., Neis, M. M., Marquardt, Y., Joussen, S., Heinrich, P. C., Merk, H. F., Hermanns, H. M., & Baron, J. M. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.183 · Cited by 45
Role of T cells in the pathogenesis of atopic dermatitis
Ogg, G. S. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03146.x · Cited by 38 · cited 1×
“The meehanisms underlying dermatitis and pruritus are eomplex and not fully understood (9, 10), but there is emerging evidenee that IL-31 may play a role.”
BackgroundDambacher, J., Beigel, F., Seiderer, J., Haller, D., Göke, B., Auernhammer, C. J., & Brand, S. (2007) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2007-988367 · Cited by 5
Cited by
Cevikbas, F., Wang, X., Akiyama, T., Kempkes, C., Savinko, T., Antal, A., Kukova, G., Buhl, T., Ikoma, A., Buddenkotte, J., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.048 · Cited by 804
Self-citationAnti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
Ruzicka, T., Hanifin, J. M., Furue, M., Pulka, G., Mlynarczyk, I., Wollenberg, A., Galus, R., Etoh, T., Mihara, R., Yoshida, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606490 · Cited by 592
Gouin, O., L’Herondelle, K., Lebonvallet, N., Le Gall-Ianotto, C., Sakka, M., Buhé, V., Plée-Gautier, E., Carré, J.-L., Lefeuvre, L., Misery, L., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0395-5 · Cited by 425
Kaufman, B. P., Guttman‐Yassky, E., & Alexis, A. F. (2018) · Experimental Dermatology · doi:10.1111/exd.13514 · Cited by 359
Cytokines and the Skin Barrier
Hänel, K., Cornelissen, C., Lüscher, B., & Baron, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14046720 · Cited by 305
Metadata
- Authors
- Hofbauer, G., Nobbe, S., Dziunycz, P., Mühleisen, B., Bilsborough, J., Dillon, Sr., & French, L.
- Venue
- Acta Dermato Venereologica
- Published
- 2012
- Volume
- 92
- Issue
- 1
- Pages
- 24-28
- ISSN
- 0001-5555 (ISSN-L)
- OpenAlex
- W2317492969
- Cited by
- 158
- References
- 30
- FWCI
- 16.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.